H2

H2 AAQS

The The AAQS of H2 (7851.TWO) as of Nov 13, 2026 is 2. In the previous year, The AAQS was 2.00 — a change of 0.00% (lower).

AAQS

2

YoY

0.00%

Last updated:

H2 has a current AAQS of 2.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock H2 in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The H2 AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2023
2.00 TWD
Jan 1, 2024
2.00 TWD
The H2 AAQS history
YEARAAQSYoY
20.00%
2—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

H2 Stock analysis

What does H2 do? H2 Inc generates revenue through its Health2Sync App, which offers a premium membership providing deeper analysis of health readings and educational content. The Patient Management Platform is sold to healthcare providers for patient prioritization and data-driven insights. Data Syncing supports integration with blood glucose meters, blood pressure monitors, weight scales, insulin pens, and CGMs, enabling seamless data import from various devices. The company serves healthcare providers, patients managing chronic conditions, and partners offering care services. Health2Sync App targets patients seeking daily management of chronic diseases through mobile and digital therapeutics, with features like tracking trends and receiving reminders. Premium members access advanced analytics and educational resources. The Patient Management Platform caters to healthcare organizations needing instant platform deployment and improved communication tools. Data Syncing facilitates connectivity with supported devices including CGM and insulin pen apps, enhancing user experience across the ecosystem. The company monetizes through subscription-based premium memberships for individual users and licensing fees for the Patient Management Platform to healthcare institutions. Data Syncing is integrated into the core product suite, driving adoption through device compatibility. Healthcare providers, chronic disease patients, and care partners form the primary customer segments purchasing these solutions. H2 is one of the most popular companies on Eulerpool.

Frequently Asked Questions about H2 stock

The AAQS of H2 is 2 in 2024.

On Eulerpool you can find the complete historical development of The AAQS H2 since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — H2

All Key Metrics — H2